Skip to main content
. 2016 Jul 26;5(7):388–389. doi: 10.1002/psp4.12080

Table 3.

Mean prediction errors and RMSE of methods for predicting HbA1c treatment outcome

Arm no. Arm Method 1 (Samtani‐SS) Method 2 (Nathan‐SS) Method 3 (Samtani) Method 4 (RBC) Method 5 (Møller)
1 Insulin glargine (comparator) −1.2 (1.5) −0.7 (1.2) −0.9 (1.3) −0.4 (1.2) −0.1 (0.6)
2 Insulin detemir −1.1 (1.4) −0.6 (1.2) −0.8 (1.2) −0.5 (1.1) −0.2 (0.7)
3 Biphasic insulin aspart −0.4 (1.4) −0.5 (1.4) −0.3 (1.3) −0.2 (1.3) −0.1 (0.7)
4 Insulin glargine (comparator) −1.2 (1.6) −0.6 (1.3) −1.0 (1.4) −0.6 (1.2) −0.2 (0.7)
5 Liraglutide 1.8mg + metformin + rosiglitazone −0.4 (0.9) −0.4 (0.9) −0.4 (0.8) −0.4 (0.9) 0.1 (0.5)
6 Metformin + rosiglitazone (comparator) −0.3 (0.9) −0.3 (1.0) −0.4 (0.9) −0.3 (1.1) 0.1 (0.7)
7 Liraglutide 1.2mg + metformin + rosiglitazone −0.4 (0.8) −0.4 (1.0) −0.5 (0.8) −0.2 (0.9) 0.0 (0.5)
8 Liraglutide 0.6mg + metformin −0.5 (1.1) −0.4 (1.2) −0.6 (1.1) −0.3 (1.0) −0.3 (0.7)
9 Liraglutide 1.8mg + metformin −0.4 (1.1) −0.5 (1.0) −0.4 (1.0) −0.3 (1.0) −0.3 (0.7)
10 Glimiperide + metformin (comparator) −0.3 (1.0) −0.4 (1.1) −0.3 (0.9) −0.4 (1.1) −0.3 (0.6)
11 Metformin −0.4 (1.0) −0.3 (1.2) −0.5 (1.0) −0.3 (1.1) 0.0 (0.7)
12 Liraglutide 1.2 mg + metformin −0.6 (1.0) −0.5 (1.0) −0.5 (1.0) −0.5 (1.1) −0.3 (0.8)
All Overall mean prediction error (mean RMSE) −0.61 (1.1) −0.47 (1.1) −0.55 (1.1) −0.37 (1.1) −0.13 (0.8)
All Overall absolute mean prediction error 0.61 0.47 0.55 0.37 0.15

Mean prediction errors and RMSE of HbA1c (%) predictions calculated as mean of individual predictions subtracted by mean of individual observations. HbA1c predictions at end of trial (26–28 weeks) were based on 12‐week data. Steady‐state predictions (Methods 1 and 2) were obtained using FPG/MPG values at 12 weeks only. Overall mean and absolute mean prediction errors are shown in bold. FPG, fasting plasma glucose; MPG, mean plasma glucose; RBC, red blood cell; RMSE, root mean square error; SS, steady state.